Episode 86 - David de Vries

https://is1-ssl.mzstatic.com/image/thumb/Podcasts211/v4/d5/e4/1e/d5e41e47-bfe8-20ea-325b-c4cfd91dca77/mza_4324065226824686757.jpg/600x600bb.jpg

The BioHub: The Top Voices in Biotech

Max Brennan - Biotech HeadHunter

115 episodes

2 days ago

Welcome to The BioHub, where the doors to the world of biotechnology swing wide open. Join your host, Max Brennan, a seasoned biotech recruiter, as he engages in thought-provoking conversations with the brightest minds in biotech. This podcast is your backstage pass to the insights, strategies, and stories that fuel success in the dynamic and ever-evolving biotech landscape. Subscribe now and be part of the conversation that's shaping the future of biotechnology. Get ready for an immersive experience into the world of biotech with The BioHub.

Life Sciences

Science

RSS

All content for The BioHub: The Top Voices in Biotech is the property of Max Brennan - Biotech HeadHunter and is served directly from their servers with no modification, redirects, or rehosting. The podcast is not affiliated with or endorsed by Podjoint in any way.

Life Sciences

Science

https://d3t3ozftmdmh3i.cloudfront.net/staging/podcast_uploaded_nologo/40170153/40170153-1704904841978-1a5f9097fe03.jpg

Episode 86 - David de Vries - Tr1X

The BioHub: The Top Voices in Biotech

24 minutes 13 seconds

1 week ago

Episode 86 - David de Vries - Tr1X

On this episode we're joined by the Co-Founder & CEO of Tr1X, David de Vries.

David and the team are building on the Nobel Prize winning research into T-reg cells of Fred Ramsdell, Shimon Sakaguchi, and Mary Brunkow, pushing that science forward by translating a Type-1 regulatory T cell program into the clinic with one goal - lasting immune balance for patients.

Their lead program TRX103 is in ph1/2 trials for GvHD and Refractory Crohn's, whilst they just received another IND clearance for TRX319, an allogeneic CD19 CAR-Tr1 therapy, to tackle Progressive MS. Tr1X pick hard problems on purpose & these indications demonstrate that.

David is an impressive leader, having co-founded Arine, and was nominated recently in BioSpace's 40 under 40 list. Tr1X are one to watch, we hope you'll enjoy the episode!